Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    2.

    Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

    Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.

    Diabetes Care. 2005 Aug;28(8):1988-94.PMID: 16043743 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.

    Miller JA, Thai K, Scholey JW.

    Diabetes. 2000 Sep;49(9):1585-9.PMID: 10969844 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus.

    Hollenberg NK, Price DA, Fisher ND, Lansang MC, Perkins B, Gordon MS, Williams GH, Laffel LM.

    Kidney Int. 2003 Jan;63(1):172-8.PMID: 12472780 [PubMed - indexed for MEDLINE]Related articles

    5.

    Insights into the regulation of renal hemodynamic function in diabetic mellitus.

    Cherney DZ, Scholey JW, Miller JA.

    Curr Diabetes Rev. 2008 Nov;4(4):280-90. Review.PMID: 18991597 [PubMed - indexed for MEDLINE]Related articles

    6.

    Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.

    Miller JA.

    J Am Soc Nephrol. 1999 Aug;10(8):1778-85.PMID: 10446946 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.

    Stevanovic RD, Price DA, Lansang MC, Fisher ND, Laffel LM, Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):78-83.PMID: 16470486 [PubMed - indexed for MEDLINE]Related articles

    8.

    Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.

    Stankovic AR, Fisher ND, Hollenberg NK.

    J Am Soc Nephrol. 2006 Dec;17(12):3293-9. Epub 2006 Nov 8.PMID: 17093063 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.

    Osei SY, Price DA, Laffel LM, Lansang MC, Hollenberg NK.

    Hypertension. 2000 Jul;36(1):122-6.PMID: 10904023 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.

    Miller JA, Curtis JR, Sochett EB.

    Diabetes. 2003 Jul;52(7):1806-11.PMID: 12829650 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine.

    Frauchiger B, Nussbaumer P, Hugentobler M, Staub D.

    Nephrol Dial Transplant. 2000 Jun;15(6):827-32.PMID: 10831635 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan.

    Price DA, Lansang MC, Osei SY, Fisher ND, Laffel LM, Hollenberg NK.

    Diabet Med. 2002 Oct;19(10):858-61.PMID: 12358875 [PubMed - indexed for MEDLINE]Related articles

    13.

    L-arginine-induced vasodilation of the renal vasculature is not altered in hypertensive patients with type 2 diabetes.

    Delles C, Schneider MP, Oehmer S, Fleischmann EH, Schmieder RE.

    Diabetes Care. 2003 Jun;26(6):1836-40.PMID: 12766119 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of the PPAR-gamma agonist rosiglitazone on renal haemodynamics and the renin-angiotensin system in diabetes.

    Lansang MC, Coletti C, Ahmed S, Gordon MS, Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2006 Sep;7(3):175-80.PMID: 17094055 [PubMed - indexed for MEDLINE]Related articles

    15.

    Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system.

    Brands MW, Fitzgerald SM.

    Am J Hypertens. 2001 Jun;14(6 Pt 2):126S-131S. Review.PMID: 11411747 [PubMed - indexed for MEDLINE]Related articles

    16.

    ACE and non-ACE pathways in the renal vascular response to RAS interruption in type 1 diabetes mellitus.

    Lansang MC, Stevanovic R, Price DA, Laffel LM, Hollenberg NK.

    Kidney Int. 2005 Mar;67(3):1033-7.PMID: 15698442 [PubMed - indexed for MEDLINE]Related articles

    18.

    Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes.

    Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA.

    J Am Soc Nephrol. 2006 Jun;17(6):1703-9. Epub 2006 May 3.PMID: 16672313 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.

    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.

    Circulation. 2008 Jun 24;117(25):3199-205. Epub 2008 Jun 16.PMID: 18559696 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Variation in the renin angiotensin system throughout the normal menstrual cycle.

    Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, Miller JA.

    J Am Soc Nephrol. 2002 Feb;13(2):446-52.PMID: 11805174 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data